BACKGROUND: The human paraoxonase (PON1) protein detoxifies certain organophosphates, and the PON1 Q192R polymorphism (rs662) affects PON1 activity. Groups with higher dose exposure to organophosphate sheep dips or first Gulf War nerve toxins reported poorer health if they had 192R, and these associations have been used to exemplify Mendelian randomization analysis. However, a reported association of 192R with depression in a population-based study of older women recently cast doubt on the specificity of the higher dose findings. We aimed to examine associations between the PON1 Q192R polymorphism and self-reported poor health and depression in two independent population-based studies. METHODS: We used logistic regression models to examine the associations in men and women aged 60-79 years from the English Longitudinal Study of Ageing (ELSA, n = 3158) and InCHIANTI (n = 761) population studies. Outcomes included the Center for Epidemiologic Studies Depression (CES-D) scale, self-rated general health status and (in ELSA only) diagnoses of depression. RESULTS: The PON1 Q192R polymorphism was not associated with self-reported poor health {meta-analysis: odds ratio (OR) = 1.01 [confidence interval (CI) 0.91-1.13], P = 0.80} or depressive symptoms in either study or in meta-analyses [CES-D: OR = 1.01 (CI 0.87-1.17), P = 0.90]. There was also no association with histories of diagnosed depression in ELSA [OR = 1.03 (CI 0.82-1.30), P = 0.80]. CONCLUSIONS: We found no evidence of an association between the PON1 Q192R polymorphism and poor general or mental health in two independent population-based studies. Neither the claimed Q192R association with depression in the general population nor its theoretical implications were supported.
BACKGROUND: The human paraoxonase (PON1) protein detoxifies certain organophosphates, and the PON1Q192R polymorphism (rs662) affects PON1 activity. Groups with higher dose exposure to organophosphatesheep dips or first Gulf War nerve toxins reported poorer health if they had 192R, and these associations have been used to exemplify Mendelian randomization analysis. However, a reported association of 192R with depression in a population-based study of older women recently cast doubt on the specificity of the higher dose findings. We aimed to examine associations between the PON1Q192R polymorphism and self-reported poor health and depression in two independent population-based studies. METHODS: We used logistic regression models to examine the associations in men and women aged 60-79 years from the English Longitudinal Study of Ageing (ELSA, n = 3158) and InCHIANTI (n = 761) population studies. Outcomes included the Center for Epidemiologic Studies Depression (CES-D) scale, self-rated general health status and (in ELSA only) diagnoses of depression. RESULTS: The PON1Q192R polymorphism was not associated with self-reported poor health {meta-analysis: odds ratio (OR) = 1.01 [confidence interval (CI) 0.91-1.13], P = 0.80} or depressive symptoms in either study or in meta-analyses [CES-D: OR = 1.01 (CI 0.87-1.17), P = 0.90]. There was also no association with histories of diagnosed depression in ELSA [OR = 1.03 (CI 0.82-1.30), P = 0.80]. CONCLUSIONS: We found no evidence of an association between the PON1Q192R polymorphism and poor general or mental health in two independent population-based studies. Neither the claimed Q192R association with depression in the general population nor its theoretical implications were supported.
Authors: L Ferrucci; S Bandinelli; E Benvenuti; A Di Iorio; C Macchi; T B Harris; J M Guralnik Journal: J Am Geriatr Soc Date: 2000-12 Impact factor: 5.562
Authors: D Buchanan; A Pilkington; C Sewell; S N Tannahill; M W Kidd; B Cherrie; J F Hurley Journal: Occup Environ Med Date: 2001-11 Impact factor: 4.402
Authors: Bharti Mackness; Paul Durrington; Andrew Povey; Stuart Thomson; Martin Dippnall; Mike Mackness; Ted Smith; Nicola Cherry Journal: Pharmacogenetics Date: 2003-02
Authors: P F Sullivan; E J C de Geus; G Willemsen; M R James; J H Smit; T Zandbelt; V Arolt; B T Baune; D Blackwood; S Cichon; W L Coventry; K Domschke; A Farmer; M Fava; S D Gordon; Q He; A C Heath; P Heutink; F Holsboer; W J Hoogendijk; J J Hottenga; Y Hu; M Kohli; D Lin; S Lucae; D J Macintyre; W Maier; K A McGhee; P McGuffin; G W Montgomery; W J Muir; W A Nolen; M M Nöthen; R H Perlis; K Pirlo; D Posthuma; M Rietschel; P Rizzu; A Schosser; A B Smit; J W Smoller; J-Y Tzeng; R van Dyck; M Verhage; F G Zitman; N G Martin; N R Wray; D I Boomsma; B W J H Penninx Journal: Mol Psychiatry Date: 2008-12-09 Impact factor: 15.992
Authors: Kimberly C Paul; Janet S Sinsheimer; Myles Cockburn; Jeff M Bronstein; Yvette Bordelon; Beate Ritz Journal: Environ Int Date: 2017-07-06 Impact factor: 9.621
Authors: Paola Zaninotto; Amanda Sacker; Elizabeth Breeze; Anne McMunn; Andrew Steptoe Journal: Aging Ment Health Date: 2015-03-16 Impact factor: 3.658